A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis
Authors:
- Edwin A. BronskyEBEdwin A. Bronsky
- Howard DruceHDHoward Druce
- Steven R. FindlaySFSteven R. Findlay
- Frank C. HampelFHFrank C. Hampel
- Harold KaiserHKHarold Kaiser
- Paul RatnerPRPaul Ratner
- Martin D. ValentineMVMartin D. Valentine
- Chester C. WoodCWChester C. Wood
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 95 (5) , 1117-1122
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine‐induced nasal secretionsClinical & Experimental Allergy, 1994
- Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: A study of its effect on their symptoms, quality of life, and nasal cytologyJournal of Allergy and Clinical Immunology, 1992
- Ipratropium bromide (atrovent nasal spray) reduces the nasal response to methacholineJournal of Allergy and Clinical Immunology, 1992
- Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClinical & Experimental Allergy, 1991
- Nonallergic Chronic Rhinitis SyndromesImmunology and Allergy Clinics of North America, 1987